Werbung
Werbung
GLMD
Galmed Pharmaceuticals Ltd.
0.84
USDGesponsert
-0.01
-0.93%
09. Jan., 15:12 UTC -5
Geschlossen
Nach-Markt
0.84
0.00
0.00%
GLMD Ergebnisberichte
Positives Überraschungsverhältnis
GLMD übertreffen die 23 der letzten 36Schätzungen.
64%
Nächster Bericht
Datum des nächsten Berichts
31. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.52
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+57.58%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/--
Galmed Pharmaceuticals Ltd. earnings per share and revenue
On 26. Nov. 2025, GLMD reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 40.09% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +12.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an increase of 57.58% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Galmed Pharmaceuticals Ltd.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Galmed Pharmaceuticals Ltd. reported EPS of -$0.33, beating estimates by 40.09%, and revenue of $0.00, -- -- expectations.
How did the market react to Galmed Pharmaceuticals Ltd.'s Q3 2025 earnings?
The stock price moved up 12.4%, changed from $0.82 before the earnings release to $0.92 the day after.
When is Galmed Pharmaceuticals Ltd. expected to report next?
The next earning report is scheduled for 31. März 2026.
What are the forecasts for Galmed Pharmaceuticals Ltd.'s next earnings report?
Based on 3
analysts, Galmed Pharmaceuticals Ltd. is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung